LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided earnings per share guidance of 3.050-3.150 for the period, compared to the consensus earnings per share estimate of 3.000. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. LivaNova […]
LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY24 earnings guidance on Wednesday. The company provided earnings per share (EPS) guidance of $3.05-3.15 for the period, compared to the consensus estimate of $3.00. LivaNova also updated its FY 2024 guidance to 3.050-3.150 EPS. LivaNova Stock Up 2.0 % Shares of LivaNova stock traded up $1.23 […]
LivaNova (NASDAQ:LIVN – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 3.050-3.150 for the period, compared to the consensus EPS estimate of 3.000. The company issued revenue guidance of $1.2 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion. LivaNova also updated its FY24 […]
LivaNova (NASDAQ:LIVN – Get Free Report) issued an update on its FY24 earnings guidance on Wednesday morning. The company provided EPS guidance of $3.05-3.15 for the period, compared to the consensus EPS estimate of $3.00. LivaNova also updated its FY 2024 guidance to 3.050-3.150 EPS. LivaNova Trading Up 2.0 % NASDAQ:LIVN traded up $1.23 during […]
CellaVision AB (publ) (OTCMKTS:CLVSF – Get Free Report) and LivaNova (NASDAQ:LIVN – Get Free Report) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their analyst recommendations, valuation, risk, institutional ownership, dividends, profitability and earnings. Profitability This table compares CellaVision AB (publ) and […]